Incidence and changes in treatment of acute exacerbation of idiopathic pulmonary fibrosis in Japan: A claims-based retrospective study.

Homma S, Suda T, Hongo Y, Yoshida M, Hiroi S, Iwasaki K, Takeshima T, Kondoh Y.

Open source

DOI
10.1016/j.resinv.2022.07.004
Published
2022-09-05
Container
Respir Investig
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.resinv.2022.07.004,
  title = {Incidence and changes in treatment of acute exacerbation of idiopathic pulmonary fibrosis in Japan: A claims-based retrospective study.},
  author = {Homma S and  Suda T and  Hongo Y and  Yoshida M and  Hiroi S and  Iwasaki K and  Takeshima T and  Kondoh Y.},
  year = {2022},
  journal = {Respir Investig},
  doi = {10.1016/j.resinv.2022.07.004},
  url = {https://doi.org/10.1016/j.resinv.2022.07.004}
}

RIS

TY  - JOUR
TI  - Incidence and changes in treatment of acute exacerbation of idiopathic pulmonary fibrosis in Japan: A claims-based retrospective study.
AU  - Homma S
AU  -  Suda T
AU  -  Hongo Y
AU  -  Yoshida M
AU  -  Hiroi S
AU  -  Iwasaki K
AU  -  Takeshima T
AU  -  Kondoh Y.
PY  - 2022
JO  - Respir Investig
DO  - 10.1016/j.resinv.2022.07.004
UR  - https://doi.org/10.1016/j.resinv.2022.07.004
ER  - 

APA

S, H., T, S., Y, H., M, Y., S, H., K, I., T, T., & Y., K. (2022). Incidence and changes in treatment of acute exacerbation of idiopathic pulmonary fibrosis in Japan: A claims-based retrospective study.. Respir Investig. https://doi.org/10.1016/j.resinv.2022.07.004

Source records